Thrombolysis and the general practitioner. 1. Practicable only under certain circumstances.
- 31 March 1990
- Vol. 300 (6728) , 867-868
- https://doi.org/10.1136/bmj.300.6728.867
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Prehospital use of APSAC: Results of a placebo-controlled studyThe American Journal of Cardiology, 1989
- Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment.Heart, 1989
- Factors influencing the time from onset of chest pain to arrival at hospitalThe Medical Journal of Australia, 1989
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Patient and general practitioner delays in acute myocardial infarctionBMJ, 1988
- Potential time saving with pre-hospital intervention in acute myocardial infarctionEuropean Heart Journal, 1988
- Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomographyThe American Journal of Medicine, 1982
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977
- Natural history of acute coronary heart attacks. A community study.Heart, 1972